FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry, and represents a method for producing drug microcapsules by a non-solvent addition differing by the fact that the drugs represent cephalosporins, while the coating is human serum albumin deposited from an aqueous solution by adding carbinol as the non-solvent and isopropanol at 25°C.
EFFECT: invention provides simplifying and fastening the microencapsulation process, reducing the microencapsulation loss (higher weight yield).
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2545723C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2538806C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2539898C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2554277C2 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2558077C2 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538807C1 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538646C1 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2538668C1 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538678C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2537251C1 |
Authors
Dates
2015-02-20—Published
2013-05-17—Filed